Niels Andreasen

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

Niels Andreasen, Camilla Hesse, Pia Davidsson et al. · Archives of Neurology · 1999 · 658 citations

Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Niels Andreasen, Lennart Minthon, Pia Davidsson et al. · Archives of Neurology · 2001 · 570 citations

Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Annika Olsson, Hugo Vanderstichele, Niels Andreasen et al. · Clinical Chemistry · 2004 · 438 citations · Full text

Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values

Magnus Sjögren, Hugo Vanderstichele, Hans Ågren et al. · Clinical Chemistry · 2001 · 436 citations · Full text